Challenges to Laboratory Monitoring of Direct Oral Anticoagulants

Challenges to Laboratory Monitoring of Direct Oral Anticoagulants

Direct oral anticoagulants (DOACs) exert anticoagulation effect by directly inhibiting Factor Xa (rivaroxaban, apixaban, and edoxaban) or thrombin (dabigatran). Though DOACs are characterized by fixed-dose prescribing and generally do not require routine laboratory drug-level monitoring (DLM), circu...

Full description

Bibliographic Details
Main Authors:	Jesse Qiao MD, Minh-Ha Tran DO
Format:	Article
Language:	English
Published:	SAGE Publishing 2024-03-01
Series:	Clinical and Applied Thrombosis/Hemostasis
Online Access:	https://doi.org/10.1177/10760296241241524

Similar Items

Laboratory Monitoring of Direct Oral Anticoagulants (DOACs)
by: Claire Dunois
Published: (2021-04-01)

Updates on Anticoagulation and Laboratory Tools for Therapy Monitoring of Heparin, Vitamin K Antagonists and Direct Oral Anticoagulants
by: Osamu Kumano, et al.
Published: (2021-03-01)

To Measure or Not to Measure: Direct Oral Anticoagulant Laboratory Assay Monitoring in Clinical Practice
by: Tania Ahuja, et al.
Published: (2023-01-01)

Current insights into the possible role of laboratory monitoring of effectiveness and safety of direct oral anticoagulants
by: S. R. Gilyarevsky, et al.
Published: (2023-07-01)

Direct oral anticoagulants (DOACs): From the laboratory point of view
by: Margetić Sandra, et al.
Published: (2022-12-01)

DIRECT ORAL ANTICOAGULANTS
by: I. Tzoran, et al.
Published: (2016-06-01)

Direct oral anticoagulant blood level monitoring in daily practice
by: R. Bavalia, et al.
Published: (2021-05-01)

Practical guidance on the use of laboratory testing in the management of bleeding in patients receiving direct oral anticoagulants
by: ten Cate H, et al.
Published: (2017-12-01)

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants
by: Emmanuel J. Favaloro, et al.
Published: (2022-02-01)

Reversal of direct oral anticoagulants
by: Almegren M
Published: (2017-07-01)

Direct Oral Anticoagulants in Patients With Active Cancer
by: Jolanda Sabatino, MD, PhD, et al.
Published: (2020-09-01)

Real-world monitoring of direct oral anticoagulants in clinic and hospitalization settings
by: Seiji Takatsuki, et al.
Published: (2017-10-01)

Emergencies on direct oral anticoagulants: Management, outcomes, and laboratory effects of prothrombin complex concentrate
by: Roisin Bavalia, et al.
Published: (2020-05-01)

Update on laboratory testing and hemostasis assessment in patients receiving direct oral anticoagulants (DOACs)
by: Vasilios Perifanis, et al.
Published: (2021-12-01)

Novel reversal agents and laboratory evaluation for direct-acting oral anticoagulants (DOAC): An update
by: Shagun B Shah, et al.
Published: (2019-01-01)

Laboratory bleeding predictors in elderly patients with atrial fibrillation taking direct oral anticoagulants
by: M. A. Gabitova, et al.
Published: (2020-01-01)

Monitoring strategies for patients treated with the new oral anticoagulants and the need for laboratory evaluation of hemostasis
by: Andrea Fontanella, et al.
Published: (2013-12-01)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
by: Matej Samoš, et al.
Published: (2022-10-01)

Changing or Retaining Direct Oral Anticoagulant After Ischemic Stroke Despite Direct Oral Anticoagulant Treatment
by: Shin‐Yi Lin, et al.
Published: (2024-02-01)

Practical issues in measuring the anticoagulant effect of direct oral anticoagulants
by: Dopsaj Violeta
Published: (2020-01-01)

Direct oral anticoagulants: A new chapter in anticoagulation therapy
by: Stepanović-Petrović Radica, et al.
Published: (2020-01-01)

Diagnostic Challenges on the Laboratory Detection of Lupus Anticoagulant
by: Armando Tripodi
Published: (2021-07-01)

Direct oral anticoagulant: Review article
by: Abdulrahman Nasiri, et al.
Published: (2022-01-01)

Direct oral anticoagulants and venous thromboembolism
by: Massimo Franchini, et al.
Published: (2016-09-01)

Direct oral anticoagulants in antiphospholipid syndrome
by: Jozélio Freire de Carvalho, et al.

Direct-acting oral anticoagulants: An overview
by: Hatem H Salem
Published: (2017-01-01)

Direct oral anticoagulants: first airbag
by: A. N. Sokolova, et al.
Published: (2019-04-01)

Direct oral anticoagulants for electrical cardioversion
by: A. N. Volovchenko, et al.
Published: (2021-07-01)

Direct Oral Anticoagulants for Inferior Vena Cava Agenesis
by: Michael Iarossi MD, et al.
Published: (2023-09-01)

Monitoring oral anticoagulation in primary care
by: Fitzmaurice, D, et al.
Published: (1996)

Monitoring oral anticoagulation in primary care.
by: Fitzmaurice, D, et al.
Published: (1996)

Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios
by: Fabiana Lucà, et al.
Published: (2023-09-01)

Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges
by: Ashley Chen, et al.
Published: (2020-07-01)

Modern possibilities and prospects in evaluating the anticoagulant effect of direct oral anticoagulants
by: A. I. Mironova, et al.
Published: (2022-06-01)

Choice of Oral Anticoagulant: Outcomes in Atrial Fibrillation Patients Post-Stroke Despite Direct Oral Anticoagulant Use
by: Eric Duong, BSc, MSc, PharmD, et al.
Published: (2023-08-01)

Exploring the implications of direct oral anticoagulants in trauma
by: Vanessa P Ho, et al.
Published: (2024-02-01)

Direct Oral Anticoagulants in Special Patient Populations
by: Asa Kessler, et al.
Published: (2023-12-01)

Use of direct oral anticoagulants in hematologic malignancies
by: Ilona Leviatan, et al.
Published: (2023-12-01)

Inherited Thrombophilia in the Era of Direct Oral Anticoagulants
by: Lina Khider, et al.
Published: (2022-02-01)

An update on applications and limitations of direct oral anticoagulants
by: Sharon Wei, et al.
Published: (2023-04-01)